Susquehanna International Group
SRTA

Susquehanna International Group’s Strata Critical Medical Inc SRTA Stock Holding History

Susquehanna International Group’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$111K Sell
26,661
-859
-3% -$4.13K ﹤0.01% 12268
2025
Q4 		$132K Buy
27,520
+7,969
+41% +$38.5K ﹤0.01% 11268
2025
Q3 		$98.9K Sell
19,551
-83,012
-81% -$367K ﹤0.01% 11572
2025
Q2 		$413K Sell
102,563
-8,046
-7% -$26.2K ﹤0.01% 9608
2025
Q1 		$302K Sell
110,609
-2,467
-2% -$8.85K ﹤0.01% 10059
2024
Q4 		$481K Buy
113,076
+84,379
+294% +$321K ﹤0.01% 8760
2024
Q3 		$84.4K Sell
28,697
-38,527
-57% -$123K ﹤0.01% 11152
2024
Q2 		$234K Sell
67,224
-1,325
-2% -$4.42K ﹤0.01% 10014
2024
Q1 		$195K Sell
68,549
-59,300
-46% -$183K ﹤0.01% 10614
2023
Q4 		$451K Buy
127,849
+57,744
+82% +$166K ﹤0.01% 8930
2023
Q3 		$182K Buy
70,105
+2,526
+4% +$8.87K ﹤0.01% 10333
2023
Q2 		$266K Buy
67,579
+36,384
+117% +$115K ﹤0.01% 9679
2023
Q1 		$105K Buy
31,195
+16,099
+107% +$65.6K ﹤0.01% 11252
2022
Q4 		$54K Sell
15,096
-47,626
-76% -$204K ﹤0.01% 11349
2022
Q3 		$253K Sell
62,722
-172,005
-73% -$883K ﹤0.01% 10243
2022
Q2 		$1.05M Sell
234,727
-129,953
-36% -$938K ﹤0.01% 6424
2022
Q1 		$3.1M Buy
364,680
+80,712
+28% +$567K ﹤0.01% 4563
2021
Q4 		$2.51M Buy
283,968
+265,899
+1,472% +$2.53M ﹤0.01% 4994
2021
Q3 		$188K Sell
18,069
-77,123
-81% -$674K ﹤0.01% 11555
2021
Q2 		$1M Sell
95,192
-268,688
-74% -$2.65M ﹤0.01% 7754
2021
Q1 		$3.74M Buy
+363,880
New +$5.06M ﹤0.01% 4488

Other funds holding SRTA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $221M AUM
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group's SRTA Position: Q1 2026 in Review

Susquehanna International Group reduced its Strata Critical Medical Inc (SRTA) stake by 3.1% in Q1 2026, selling an estimated $4.13K and leaving 26,661 shares worth $111K. The position accounts for ﹤0.01% of the portfolio, ranked #12268.

Susquehanna International Group first reported a position in SRTA in Q1 2021 and has held it in 21 quarters since. The position peaked at $3.74M in Q1 2021. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

  • Susquehanna International Group held 26,661 shares of Strata Critical Medical Inc worth $111K as of Q1 2026.
  • Susquehanna International Group sold 859 Strata Critical Medical Inc shares in Q1 2026, an estimated $4.13K.
  • Strata Critical Medical Inc made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12268 holding.
  • Susquehanna International Group first reported a position in Strata Critical Medical Inc in Q1 2021 and has held it in 21 quarters since.
  • Susquehanna International Group's Strata Critical Medical Inc position peaked at $3.74M in Q1 2021.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.